FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147107941> ?p ?o ?g. }

• W2147107941 endingPage "491" @default.
• W2147107941 startingPage "482" @default.
• W2147107941 abstract "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has received considerable attention as a potential anticancer agent. However, recombinant Apo2L/TRAIL has several limitations, which include a weak pharmacokinetic profile, namely, a short biological half-life and rapid renal clearance, and an inability to form a homotrimeric structure. In this research, we attempted to develop a sustained release nanoparticle (NP) formulation that stabilizes Apo2L/TRAIL and preserves its antitumor activity. Apo2L/TRAIL-loaded human serum albumin (HSA) NPs were prepared using a desolvation technique optimized by particle size, zeta-potential, and entrapment efficiency. Apo2L/TRAIL in HSA-NPs continuously released over 24 h at 37°C in phosphate buffered saline and rat plasma condition, and the biological activity of Apo2L/TRAIL-HSA-NPs was preserved (IC50=67.2 ng/mL versus Apo2L/TRAIL IC50=55.4 ng/mL) with negligible activity loss. Furthermore, in vivo pharmacokinetic profiles and tumor distribution demonstrated the superiority of Apo2L/TRAIL-HSA-NPs over Apo2L/TRAIL. The circulating half-life period was significantly prolonged from 9.8 to 90.7 min (9.2-fold enhancement), and drug bioavailability was clearly enhanced on the basis of area under the curve analysis (2.7-fold). And tumor distribution of Apo2L/TRAIL-HSA-NPs was also increased at 1 h after injection, which was about 14-fold (1-h point) over that of Apo2L/TRAIL. These results show that Apo2L/TRAIL-loaded HSA-NPs should be considered as potential long-acting cancer agents." @default.
• W2147107941 created "2016-06-24" @default.
• W2147107941 creator A5023503973 @default.
• W2147107941 creator A5026222112 @default.
• W2147107941 creator A5028747348 @default.
• W2147107941 creator A5037222272 @default.
• W2147107941 creator A5041053589 @default.
• W2147107941 creator A5044884424 @default.
• W2147107941 creator A5048381976 @default.
• W2147107941 creator A5057717132 @default.
• W2147107941 creator A5062499600 @default.
• W2147107941 date "2011-02-01" @default.
• W2147107941 modified "2023-10-18" @default.
• W2147107941 title "Preparation and Characterization of Apo2L/TNF-Related Apoptosis-Inducing Ligand–Loaded Human Serum Albumin Nanoparticles with Improved Stability and Tumor Distribution" @default.
• W2147107941 cites W1484817497 @default.
• W2147107941 cites W1647414470 @default.
• W2147107941 cites W1964944871 @default.
• W2147107941 cites W1978353140 @default.
• W2147107941 cites W1984571287 @default.
• W2147107941 cites W1990455420 @default.
• W2147107941 cites W1996697333 @default.
• W2147107941 cites W2009514589 @default.
• W2147107941 cites W2015879631 @default.
• W2147107941 cites W2025017345 @default.
• W2147107941 cites W2026803997 @default.
• W2147107941 cites W2027312482 @default.
• W2147107941 cites W2047833244 @default.
• W2147107941 cites W2056217426 @default.
• W2147107941 cites W2062175712 @default.
• W2147107941 cites W2064228157 @default.
• W2147107941 cites W2066119709 @default.
• W2147107941 cites W2074049796 @default.
• W2147107941 cites W2082511916 @default.
• W2147107941 cites W2085886170 @default.
• W2147107941 cites W2102630679 @default.
• W2147107941 cites W2104939095 @default.
• W2147107941 cites W2133862707 @default.
• W2147107941 cites W2169103384 @default.
• W2147107941 cites W2169344120 @default.
• W2147107941 doi "https://doi.org/10.1002/jps.22298" @default.
• W2147107941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20669330" @default.
• W2147107941 hasPublicationYear "2011" @default.
• W2147107941 type Work @default.
• W2147107941 sameAs 2147107941 @default.
• W2147107941 citedByCount "40" @default.
• W2147107941 countsByYear W21471079412012 @default.
• W2147107941 countsByYear W21471079412014 @default.
• W2147107941 countsByYear W21471079412015 @default.
• W2147107941 countsByYear W21471079412016 @default.
• W2147107941 countsByYear W21471079412017 @default.
• W2147107941 countsByYear W21471079412018 @default.
• W2147107941 countsByYear W21471079412019 @default.
• W2147107941 countsByYear W21471079412020 @default.
• W2147107941 countsByYear W21471079412021 @default.
• W2147107941 countsByYear W21471079412022 @default.
• W2147107941 countsByYear W21471079412023 @default.
• W2147107941 crossrefType "journal-article" @default.
• W2147107941 hasAuthorship W2147107941A5023503973 @default.
• W2147107941 hasAuthorship W2147107941A5026222112 @default.
• W2147107941 hasAuthorship W2147107941A5028747348 @default.
• W2147107941 hasAuthorship W2147107941A5037222272 @default.
• W2147107941 hasAuthorship W2147107941A5041053589 @default.
• W2147107941 hasAuthorship W2147107941A5044884424 @default.
• W2147107941 hasAuthorship W2147107941A5048381976 @default.
• W2147107941 hasAuthorship W2147107941A5057717132 @default.
• W2147107941 hasAuthorship W2147107941A5062499600 @default.
• W2147107941 hasBestOaLocation W21471079411 @default.
• W2147107941 hasConcept C104317684 @default.
• W2147107941 hasConcept C112705442 @default.
• W2147107941 hasConcept C150903083 @default.
• W2147107941 hasConcept C165616093 @default.
• W2147107941 hasConcept C17991360 @default.
• W2147107941 hasConcept C181389837 @default.
• W2147107941 hasConcept C185592680 @default.
• W2147107941 hasConcept C190283241 @default.
• W2147107941 hasConcept C202751555 @default.
• W2147107941 hasConcept C203014093 @default.
• W2147107941 hasConcept C207001950 @default.
• W2147107941 hasConcept C2776125364 @default.
• W2147107941 hasConcept C2777752497 @default.
• W2147107941 hasConcept C2778597219 @default.
• W2147107941 hasConcept C40767141 @default.
• W2147107941 hasConcept C55493867 @default.
• W2147107941 hasConcept C71924100 @default.
• W2147107941 hasConcept C86803240 @default.
• W2147107941 hasConcept C98274493 @default.
• W2147107941 hasConceptScore W2147107941C104317684 @default.
• W2147107941 hasConceptScore W2147107941C112705442 @default.
• W2147107941 hasConceptScore W2147107941C150903083 @default.
• W2147107941 hasConceptScore W2147107941C165616093 @default.
• W2147107941 hasConceptScore W2147107941C17991360 @default.
• W2147107941 hasConceptScore W2147107941C181389837 @default.
• W2147107941 hasConceptScore W2147107941C185592680 @default.
• W2147107941 hasConceptScore W2147107941C190283241 @default.
• W2147107941 hasConceptScore W2147107941C202751555 @default.
• W2147107941 hasConceptScore W2147107941C203014093 @default.
• W2147107941 hasConceptScore W2147107941C207001950 @default.
• W2147107941 hasConceptScore W2147107941C2776125364 @default.

• next